Teleflex Inc (TFX) reports a 2.8% revenue increase and a 15.1% rise in adjusted EPS, while announcing a strategic acquisition and share repurchase program to drive future growth.

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.